On the other hand, EBV(–) PTLD displayed similar recurrent aberrations (gain of 3/3q and 18q and loss of 6q23/TNFAIP3 and 9p21/CDKN2A) as compared with IC-DLBCL. Here, CDKN2A is linked to post-transplant lymphoproliferative disease.